TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Haemonetics Corporation (HAE)

Healthcare Medical Devices
86.80 $
+1.5% vs. previous close
Closing price · As of: 3. Aug 2026

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 2,396 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet HAE
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
1,962 2,011 2,200 2,196 2,541 2,525 2,531 2,451 2,462 2,442 2,491 2,396
802 866 765 769 979 956 1,006 935 913 900 944 835
286 351 194 179 344 299 321 307 293 296 363 245
286 351 194 179 344 299 321 307 293 296 363 245
177 174 212 207 201 214 212 203 201 207 196 217
289 286 304 317 374 382 360 365 361 336 321 306
304 308 – – – 300 286 284 287 292 297 –
466 465 555 565 613 616 605 604 607 606 607 656
268 251 429 406 495 488 466 456 451 428 420 448
1,098 1,118 1,257 1,236 1,636 1,646 1,624 1,630 1,580 1,593 1,579 1,600
237 264 262 300 260 274 253 578 531 548 540 283
14 14 14 10 5.1 5.4 5.1 304 304 304 305 5.0
78 80 57 73 77 69 63 67 46 62 49 51
751 749 857 798 1,218 1,220 1,220 921 921 920 920 1,220
865 894 943 960 905 879 907 821 882 849 911 796
284 309 340 360 387 369 392 352 356 336 381 279
51 51 51 51 52 51 51 49 48 48 47 46

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?